Page last updated: 2024-08-16

rabeprazole and gefarnate

rabeprazole has been researched along with gefarnate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azuma, T; Fujisawa, T; Fujita, T; Hayakumo, T; Inokuchi, H; Kawai, T; Kutsumi, H; Kuwayama, H; Matsubara, Y; Miyaji, H; Murakami, M; Sanuki, T; Terao, S; Yamazaki, Y; Yoshida, S	1

Trials

1 trial(s) available for rabeprazole and gefarnate

Article	Year
Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial. Journal of gastroenterology, 2012, Volume: 47, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Esophagitis; Female; Gefarnate; Humans; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Prospective Studies; Rabeprazole; Secondary Prevention	2012

Article

Year

Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial.

Journal of gastroenterology, 2012, Volume: 47, Issue:11

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Esophagitis; Female; Gefarnate; Humans; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Prospective Studies; Rabeprazole; Secondary Prevention

2012